These cell adhesion molecules as targets of Ca2+ influx/O-GlcNAcylation axis could have a major clinical implication in MM therapies since ITGA4 and ITGB7 are highly expressed in the majority of MM tissues, but not in NPCs. The gene discussed is ITGA4; the disease is Miyoshi myopathy.